Companies in The Medical Capital attracted over $2.3 billion in growth capital since 2001; with more than $1 billion raised in the past four years alone.

In 2017, The Medical Capital attracted $218 million in new biomedical equity investments. Forty to fifty Northeast Ohio companies routinely raise an average of $200M annually in private investment capital.

“Santé Ventures looks across the nation to find the combination of exceptional entrepreneurs and world class technology. This is a very hard combination to find. We have found it repeatedly in Northeast Ohio.  I think that is because of a rare combination of world class doctors and researchers and a culture of innovation. That culture is the secret ingredient. That takes leadership and mentorship. And we have found both in abundant supply.”

Joe Cunningham, M.D, Managing Director, Santé Ventures

There are 36 Cleveland-area biomedical investors including:

Venture Capital and Growth Equity Firms  >

Acquire Investments
Arsenal Venture Partners
Blue Point Capital
Bridge Investment Fund
Cascade Partners
Draper Triangle Ventures
Early Stage Partners
Edgewater Capital
Everett Partners
Glengary Ventures
Hopen Life Science Ventures
Kirtland Capital Partners
Mutual Capital Partners
NDI Healthcare Fund
NewVista Group
North Coast Venture Fund
Primus Capital
RIK Enterprises
Riverside Company
RiverVest Ventures
Roulston Ventures

Angel Fund and Networks  >

Akron ARCHAngel Network
North Coast Angel Fund
RMS Investment Corporation
Second Generation
Zapis Capital Group

Seed Funds  >

Akron BioInvestments Funds
Cleveland Clinic Biovalidation Fund
Digital C
Global Cardiovascular Innovation Center
The Harrington Institute
JumpStart Funds
Lorain Community College Fund
Valley Growth Ventures

There are 123 National & International Investors in The Medical Capital companies, including:

Boston  >

Ampersand Capital Ventures
Bain Capital Ventures
Boston Scientific
Capital Resource Partners
CompuGroup Medical
DSM Venturing
Excel Venture Management
Fidelity Biosciences
Fletcher Spaght Ventures
HealthCare Ventures
MPM Capital
Nautic Partners
Norwich Ventures
Polaris Partners
RA Capital
Siemens Venture Capital
Summit Partners
Tekla Capital Management

New York Area  >

Accelerator Corporation
Accipiter Capital Management
Aisling Capital
Amphion Innovations
Aperture Venture Partners
Behrman Capital
Clayton, Dubilier & Rice
Cortec Group
Cowen Group
Easton Capital Investment Group
Foundation Medical Partners
Frountcourt Ventures
Goldman Sachs
Great Point Partners
Investor Growth Capital
Life Sciences Capital
MSD Capital
New Science Ventures
North Peak Capital
Oak Investment Partners
Orbimed Advisors
Psilos Group
Radius Ventures
Sunrise Equity Partners
Tenex Capital
Toucan Capital
Welsh, Carson, Anderson & Stowe

West Coast  >

3X5 Partners
ABS Capital Partners
Alexandria Venture Investments
Alliance of Angels
The Compass Group
DW Healthcare Partners
Francisco Partners
Health Velocity Capital
HLM Venture Partners
Kearny Venture Partners
Palo Alto Investors
SV Life Sciences
Takeda Ventures
TPG Biotech
Vivo Capital
WRF Capital
Watson Fund
Western Technology Investment

Midwest  >

Advantage Capital Partners
Allos Ventures
Arch Venture Partners
Aspire Capital
Baird Capital Partners
Beecken Petty O’Keefe & Company
Blue Chip Venture Company
Bluestem Cpaital
Charter Life Sciences
Chrysalis Ventures
CID Capital
Cressey & Company
Draper Triangle Ventures
Drive Capital
Eli Lilly
First Analysis
Kentucky Seed Capital Fund
Ohio Innovation Fund
Ohio TechAngels
Osage University Partners
Queen City Angels
Rev1 Vetures
River Cities Capital Funds
SWMF Life Science
Thoma Bravo
Thomas, McNerney & Partners
Triathlon Medical Venture Partners
Venture Investors
West Capital Advisors

South  >

Austin Ventures
Black Beret Life Sciences
EDG Partners
Heritage Group
Maverick Capital
Mayport Venture Partners
MB Venture Partners
Pappas Ventures
River Associates Investments
Santé Ventures
Tiberius ll
TriStar Technology Ventures

International  >

Arix Bioscience
MBL Venture Capital
WuXi AppTec
Xeraya Capital